What is the Market's View on Cortexyme Inc (CRTX) Stock's Price and Volume Trends Thursday?

Thursday, July 21, 2022 03:23 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Cortexyme Inc (CRTX) Stock's Price and Volume Trends Thursday?

The market has been high on Cortexyme Inc (CRTX) stock recently. CRTX gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Cortexyme Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CRTX!

See Full CRTX Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With CRTX Stock Today?

Cortexyme Inc (CRTX) stock has fallen -5.36% while the S&P 500 is up 0.6% as of 3:21 PM on Thursday, Jul 21. CRTX has fallen -$0.12 from the previous closing price of $2.24 on volume of 543,697 shares. Over the past year the S&P 500 has fallen -7.85% while CRTX has fallen -96.33%. CRTX lost -$2.96 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Cortexyme Inc click here.

More About Cortexyme Inc

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics. Click Here to get the full Stock Report for Cortexyme Inc stock.